The endocannabinoid system (ECS) has a widespread neuromodulatory function in the central nervous system and is involved in important aspects of brain function including brain development, cortical rhythms, plasticity, reward, and stress sensitivity. Many of these effects are mediated via the cannabinoid CB1 receptor (CB1R) subtype. Animal studies convincingly show an interaction between the ECS and sex hormones, as well as a sex difference of higher brain CB1R in males. Human in vivo studies of sex difference have yielded discrepant findings.
Introduction
The endocannabinoid system (ECS) is a ubiquitous modulatory and homeostatic system in the human body (Laprairie et al., 2012) . In the central nervous system, the ECS is involved in multiple neurodevelopmental processes (Harkany et al., 2007) , cognitive functions (Kruk-Slomka et al., 2016) , and the regulation of emotion and responses to stress (Lutz et al., 2015) . The ECS consists of lipid derived endocannabinoid ligands, the enzymes constituting their metabolic routes, and two G-protein coupled receptors -endocannabinoid receptor type 1 and 2 (CB1R and CB2R respectively). The main endocannabinoids, anandamide (AEA) and 2-arachidonoylglycerol (2-AG) are synthesised on the postsynaptic membrane in response to depolarization. They modulate neural activity by acting retrogradely on presynaptic CB1R to transiently suppress further neurotransmitter release. Additionally, the ECS can affect synaptic plasticity through long-term depression of function (LTD) (Lu and MacKie, 2016) . The main functional site of ECS modulation has been proposed to be at glutamatergic and GABAergic synapses resulting in balancing excitation and inhibition of cortical pyramidal cells, and local circuit modulation of midbrain projections (Lu and MacKie, 2016; Skosnik et al., 2016; Covey et al., 2017) . It is currently unclear whether these roles of ECS in plasticity and neurodevelopment have an impact on known sex differences in histology and morphology of the human cortex (Rabinowicz et al., 2002; Sowell et al., 2007) .
Converging lines of evidence from pre-clinical studies show gender differences in ECS function. Relative to female rodents, male rodents show greater levels of CB1R protein (Reich et al., 2009) , mRNA (Gonz alez et al., 2000) , receptor density (Mateos et al., 2011; Llorente-Berzal et al., 2013) and agonist binding (Dow-Edwards et al., 2016) . However, in vivo studies investigating CB1R availability in humans have yielded discrepant findings, reporting decreased and increased CB1R availability in males relative to females (Neumeister et al., 2013; Normandin et al., 2015; Van Laere et al., 2008) . These widespread or global differences were measured in comparable samples of healthy control subjects without recent cannabis exposure, but unfortunately comparison is hampered by differences in quantification and properties of CB1R PET radioligands (Horti and Laere, 2008) .
Development of the ECS can be described as transactional. Preclinical studies showing ECS sex differences in response developmental stress exposure suggest that environmental factors may contribute to different adult ECS phenotypes in males and females (Reich et al., 2009; Llorente-Berzal et al., 2013; Su arez et al., 2009) . Additionally, chronic exposure to a CB1R agonist during early development results in long term sex dependent changes in cognitive performance in rats (Mateos et al., 2011) . This is in line with human data suggesting greater impact of chronic cannabis exposure to visuospatial memory performance in females (Pope et al., 1997) . Human studies generally associate the ECS with cognition (Broyd et al., 2016) . In a recent double blind placebo controlled crossover study a low dose of sublingual Δ9-THC resulted in reduction of spatial span task errors in males, and an increase in females (Makela et al., 2006) . This sex dependent effect of the ECS on visuospatial performance is notable as this domain seems to have sex differences in humans (Voyer et al., 2017) . Animal studies consistently support the association of visuospatial memory and the ECS (Yim et al., 2008; Jentsch, 1997; S. V et al., 2001; Wise et al., 2012; Abush and Akirav, 2009; Robinson et al., 2008) ; e.g. spatial working memory is selectively impaired in male rhesus monkeys after i.v. Δ9-THC injection (Verrico et al., 2014) .
CB1R availability in the human brain is proportional to tracer binding measured as tracer distribution volume (V T ) using compartmental modelling (Terry et al., 2009 ). V T is defined as the relationship of tissue concentration of bound radioligand (C T ) to plasma concentration of unchanged radioligand (C P ) at kinetic equilibrium (Innis et al., 2007) . We used [ 18 F]FMPEP-d2, a novel inverse agonist CB1R PET radioligand, to measure CB1R availability in healthy male and female volunteers. The retest variability of [ 18 F]FMPEP-d2 plasma measurements are good (16%), uptake into the human brain is high, and binding is highly specific (80-90%) . Similarly, the test-retest variability (14%), intersubject variability (26%), and intra-class correlation (ICC ¼ 0.89) of [
18 F]FMPEP-d2 V T are good (Terry et al., 2010a (Terry et al., , 2010b . Despite being highly lipophilic the combination of [ 18 F]FMPEP-d2 test-retest stabilities of V T /plasma measurements and binding specificity seem to be superior to other currently available CB1R PET radioligands (Normandin et al., 2015; Terry et al., 2010a; Burns et al., 2007; Sanabria-Boh orquez et al., 2010; Horti et al., 2006) .
Previous studies have successfully used [ 18 F]FMPEP-d2 V T to demonstrate group effects of chronic cannabis use and alcohol dependence on CB1R availability . In addition to substance-related disorders, the ECS has also been suggested to be involved in the etiology of other psychiatric disorders, such as mood and anxiety disorders (Neumeister et al., 2013; Micale et al., 2013) , and schizophrenia (Jenko et al., 2012; Ranganathan et al., 2016) . The clinical use of CB1R antagonist rimonabant increased the risk for significant depressive symptoms in patients with obesity/metabolic disorders (Van Gaal et al., 2008) leading to withdrawal from market. Considering the consistent gender differences in incidence of these psychiatric disorders, and the widespread role of ECS in brain function, characterizing a ECS sex difference could lead to novel insight into the vulnerability mechanisms of neuropsychiatric disorders. We hypothetized that males would show greater CB1R availability relative to females using [ 18 F]FMPEP-d2
and 3D-PET. We also explored whether CB1R is associated with neuropsychological function.
Materials and methods
The study protocol was approved by the Joint Ethical Committee of the University of Turku and the Turku University Central Hospital. The study was conducted according to the Declaration of Helsinki. Informed consent was obtained from all human subjects prior to their participating in the study.
Subjects
We recruited 28 healthy individuals from the national population registry, local educational institutions, and by local newspaper advertisement. The somatic status of all the subjects was confirmed by medical examination, blood and urine tests, electrocardiography, and a structured clinical interview for DSM-IV axis I disorders (SCID-I/NP). Pregnancy was ruled out by urine and/or blood screening. Subjects with a chronic medical or neurological condition affecting the brain, history of head trauma with loss of consciousness, and neurodevelopmental disorders were excluded. Lifetime substance use was documented, and current use was controlled with a urine screen prior to the PET scan. Subjects with a lifetime DSM-IV Axis I diagnosis, substance-related disorder, or who had used any illicit substances two months prior to scanning, were excluded. All subjects underwent a structural MRI scan with the Philips 3T Ingenuity PET/MR hybrid scanner to exclude any structural abnormalities. Four subjects were ruled out from statistical tests due to technical failure resulting in incomplete blood data (n ¼ 3) or incomplete PET data (n ¼ 1). Two subjects with frame-by-frame motion exceeding 4 mm, and significant or continuous motion in tracking data, were excluded. Overall, the study sample regarding statistical tests of [ 18 F]FMPEP-d2 V T consisted of 22 of the 28 scanned subjects. To approximate serum estradiol concentration during PET, the phase of ovarian cycle of females was determined as either early follicular (<9 d), late luteal (>24 d), or late follicular to mid-luteal phase (9-23 d) according to days from start of last menstruation (Stricker et al., 2006) . Use of hormonal contraception or menopause were documented as these affect serum estradiol levels (Mishell et al., 1972) . Six females had combined oral contraceptives containing estrogen and progestin, four had no contraception and one subject had a recent menopause. According to ovarian cycle no subjects without contraception was in the 'late follicular to mid-luteal' phase. The cycle phase for one female subject could not be classified due to missing data.
Radiochemistry
[ 18 F]FMPEP-d2 was synthesized as described previously (Donohue et al., 2008) with slight modifications. The radiochemical purity was greater than 95% and the molar radioactivity greater than 500 GBq/μmol at the end of synthesis.
Positron emission tomography
An individually molded thermoplastic mask was used to restrain head movement during the scan. The tracer [ 18 F]FMPEP-d2 was given as an antecubital intravenous bolus injection. Emission data was gathered in 3D list-mode first for 60 min with the brain-dedicated high-resolution research tomograph (ECAT HRRT, Siemens Medical Solutions). Subjects then came out of the scanner for 30 min, after which the scan was continued for another 30 min for a total scan range of 0-120 min.
Emission data were reconstructed using a 3D-OSEM algorithm into 19 frames of increasing length (3 Â 1 min, 5 Â 3 min, 7 Â 6 min and 4 Â 7.5 min) with a 1.22 Â 1.22 Â 1.22 mm 3 isometric voxel-size. Head motion during the scan was corrected by realigning all PET frames to the 12th frame containing the highest uptake on average. Individual frameto-frame motion correction parameters were inspected and subjects with motion exceeding a predefined 4 mm in any direction were scrutinized using head motion tracking data collected during the scan (Polaris, Northern Digital Inc., Canada , and mimicked the exhaustive or composite VOIs used in previous human studies of CB1R sex difference (Neumeister et al., 2013; Normandin et al., 2015; Van Laere et al., 2008) . Mean time activity curves were derived from all 17 VOIs (amygdala, anterior cingulate cortex, brainstem, caudate nucleus, cerebellum, frontal cortex, hippocampus, insula, occipital cortex, orbitofrontal cortex, parahippocampal gyrus, parietal cortex, posterior cingulate cortex, prefrontal cortex, putamen, temporal cortex and thalamus).
Arterial plasma sampling and analyses for input function
Following tracer injection, whole blood activity was measured using continuous sampling for the first 3.5 min using Allogg ABSS (Allogg AB, Mariefred, Sweden, http://www.allogg.se), after which manual samples were drawn from a radial artery cannula at 4. 5, 7.5, 11,15, 20, 25, 30, 35, 40, 45, 50 and 60 min. Plasma metabolite samples were also manually drawn from the radial artery at 4.5, 11, 15, 20, 30, 45 and 60 min. The amount of unchanged [
18 F]FMPEP-d2 and its radioactive metabolites were analysed from arterial plasma samples using thin-layer chromatography and digital autoradiography; see supplementary methods for details.
Plasma input curve preprocessing
Decay corrected whole blood tissue activity curves (TAC) derived from automatic blood pump sampling were converted to plasma activity using hematocrit and a population derived tracer specific distribution function. Automated and manual plasma sample TACs were then combined. Plasma TAC values were extrapolated from 60 to 120 min using a biexponential function fit starting at two times the peak activity location. The measured and estimated plasma activities were corrected for the fraction of unchanged tracer, which was interpolated with a Hill-function fit to the measured un-metabolized fraction time series. The time delay of the peak radioactivity reaching tissue and blood samples was corrected using PET count rate curves to reference of peak tissue activity. The resulting plasma activity concentration curve, corrected for metabolites, was used as parent input for modeling.
Assessment of confounding factors in blood data
To assess sources of variation in V T, statistical tests of blood data were done with sex as the independent variable. Areas under curve (AUC) for parent input and unchanged tracer fraction time series were calculated with the linear trapezoidal method using GraphPad Prism version 6.00 (GraphPad Software, La Jolla California USA, www.graphpad.com). Sex differences of whole parent input AUC means were compared with Student's t-test. Repeated measures analysis of variance (rmANOVA) within the general linear model framework (GLM) was used to test for a significant group effect or time*sex interaction in unchanged tracer fractions. Associations of blood data to body mass index (BMI) and age were explored by calculating Pearson correlation coefficients. The sources of variance in parent input were modeled with linear regression using body surface area (BSA), injected activity and AUC of unmetabolized tracer fraction as independent variables.
Tissue data characterization
Individual tissue time activity curves (TTAC) were visually inspected for quality. There were no significant hemispheric differences of regional V T (df ¼ 1, F ¼ 0.563, p ¼ 0.461) in an rmANOVA model including all 17 ROIs and two hemispheres as within-subject factor levels. V T from VOIs containing both hemispheres from the amygdala, anterior cingulate cortex, brainstem, cerebellum, frontal cortex, hippocampus, insula, nucleus caudatus, occipital cortex, orbitofrontal cortex, parahippocampal cortex, parietal cortex, posterior cingulate cortex, prefrontal cortex, putamen, temporal cortex and thalamus were chosen for further statistical testing.
Modeling of VOI V T and subgroup comparisons
In this study regional [ . Logan plot adds minor underestimation bias due to noise and provides robust measurements of V T at both regional and voxel level (Logan, 2003) . A substantial proportion of CB1R has been found to be internalized behind the neuronal plasma membrane (Hsieh et al., 2002) . The proportion of internalized receptors might vary between brain regions. Logan plot permits not assuming a uniform model structure for the whole brain. Modeling was done with in-house developed software, which is freely available for download online (http://www.turkupetcentre.net/software/). Shapiro-Wilks test was used to test the normality assumption. Correlations with subject age and BMI were assessed with Pearsons r correlations. Repeated measures ANOVA was used to test for differences in V T between sexes. Greenhouse-Geisser correction was used when sphericity assumption was violated. Results from rmANOVA were reassured by leaving out thalamic and caudate nucleus VOIs in which the normality assumption was violated. Group differences in these two VOIs were tested with Mann-Whitney U test. P-values <0.05 were considered statistically significant. All statistical testing was done with IBM SPSS Statistics 23 software (IBM corp. Armonk, NY, USA).
Voxel-wise modeling and statistical testing of V T
Parametric images of V T were calculated to discover the maximal sources of variance within regions, and to reassure results from VOI tests. First, the skull signal was masked out to minimize the effect of Gaussian filtering activity from skeletal [ 18 F]fluoride accumulation onto the cortical signal. The motion corrected PET images were then Gaussian filtered to the approximate spatial resolution (FWHM 3 mm) of HRRT to increase signal to noise ratio. Freely available in-house software was used to calculate voxel-wise V T (http://www.turkupetcentre.net/software/). Modeling was started from the frame starting at 42 min without V T constraints. The parametric volume was then Gaussian filtered (FWHM 10 mm) and normalized to standard MNI space using transformations obtained by aligning the T1 weighted MR image to a standard MNI template using SPM12. Concordance of VOI level V T from the prefrontal cortex and putamen were tested against mean V T from corresponding areas of MNI normalized parametric volumes using Pearson r correlations. An independent sample t-test was done with SPM12 to compare groups at voxel level. The threshold of statistical significance used in the VOI level tests of sex difference (p < 0.05) was used as peak threshold for corresponding parametric t-tests. In exploratory analyses, the peak threshold was set at p < 0.001. In all parametric analyses the FDR corrected cluster threshold was p < 0.05 and the extent threshold was adjusted to the size of the smallest significant cluster.
Neuropsychological testing
All subjects participated in neuropsychological testing including Trail Making Test A (TMT-A), Brief Visuospatial Memory Test (BVMT), a visuospatial working memory task (Spatial Span), word fluency, Hopkins Verbal Learning Test (HVLT) and Continuous Performance Test (CPT-IP).
Gender differences in performance were tested for each test separately using univariate GLM including age as a covariate.
Results
All subjects were of Finnish ancestry. Males and females did not differ in age, years of education, level of functioning, smoking status, handedness, average movement during PET scan or injected tracer activity; Table 1 . Additionally, there were no differences in self-reported anxiety (Beck Anxiety Inventory). Males had a larger body surface area than females (df ¼ 20, t ¼ 4.496, p < 0.001), but there was no difference in BMI (p ¼ 0.250). There were no significant correlations between age (p > 0.150) or BMI (p > 0.180) and V T in any VOI, with or without controlling for sex. There were no significant differences of V T between hemispheres (df ¼ 1, F ¼ 0.563, p ¼ 0.461). Therefore, V T from bilateral VOIs were used in statistical models. Results of statistical tests of blood data, and comparison of parametric and ROI V T, can be found in supplement 2. A figure showing the time series of mean un-metabolized tracer fractions in males and females separately can be found in supplement 3.
Region of interest analyses of CB1R V T in males and females
The V T of [
18 F]FMPEP-d2 was higher in males compared to females Fig. 1. Inter-subject variation was similar in male and female groups. However, females using oral contraceptives tended to have lower mean V T than females without contraception or recent menopause. Due to low number of subjects in the subgroups no further statistics were attempted; Fig. 2 .
Parametric image analyses
A voxel-wise t-test showed one large significant cluster of higher V T in males than females (kE ! 250679, p FDR-corr <0.001); Fig. 3 . Voxel-wise regression analyses revealed two significant clusters (p FDR-corr <0.05) of parametric V T correlated negatively with visuospatial working memory task (Spatial span) performance. Sex was used as a covariate; Fig. 4 . However, only the left hemisphere cluster survived correcting the cluster extent threshold for multiple comparisons (p FWER-corr <0.008). There were no gender differences in visuospatial working memory test scores in this sample (df ¼ 20, t ¼ À0.537, p ¼ 0.597), nor significant associations of other neuropsychological test performance with parametric CB1R V T .
Discussion
In this study we found a higher V T of [ (Mateos et al., 2011; Llorente-Berzal et al., 2013; Dow-Edwards et al., 2016) . Also, higher anterior pituitary CB1R mRNA and hippocampal CB1R protein levels have been measured in male rats using in situ hybridization and western blot experiments (Reich et al., 2009; Gonz alez et al., 2000) . Sex differences in ECS responses to stress have also been reported. CB1R agonist [ While preclinical results largely parallel each other, previous human PET studies on sex difference of brain CB1R are inconsistent. Lower CB1R V T was reported in males using [ 11 C]OMAR PET (Neumeister et al., 2013; Normandin et al., 2015) , while an opposite finding was reported by another study using standardized uptake values of [
18 F]MK-9470 PET (Van Laere et al., 2008) . The human studies on CB1R sex difference are largely comparable in terms of age, BMI and years of education of healthy control subjects. However, since the ECS interact bi-directionally with ]FMPEP-d2 is higher in males (grey bars, n ¼ 11) than in females (black bars, n ¼ 11) in a regionally differential manner. The bars, representing group means in 17 VOIs, are arranged in order of increasing maximum mean V T . Error bars indicate standard error of mean. Abbreviations: BSTEM, brainstem; THA, thalamus; CER, cerebellum; OCC, occipital cortex; HIPP, hippocampus; CAU, caudate nucleus; PHIPP, parahippocampal gyrus; PAR, parietal cortex; PCC, posterior cingulate cortex; AMY, amygdala; FC, frontal cortex; PFC, prefrontal cortex; INS, insula; OFC, orbitofrontal cortex; TEMP, temporal cortex; ACC, anterior cingulate cortex; PUT, putamen. *P < 0.05; **P < 0.01, repeated measures ANOVA. Female subjects using combined oral contraceptives, no contraceptives, or in menopause are denoted with either closed squares (■, n ¼ 6), open squares ( , n ¼ 4), or a diamond (◆, n ¼ 1), respectively. Fig. 3 . Statistical parametric mapping (SPM) analysis shows one cluster of higher V T in males (n ¼ 11) compared to females (n ¼ 11). The cluster, visualized here in two horizontal planes representing high T-values, was significant after FDR correction (p FDR-corr <0.001, kE ! 250679). The lower limit of the color bar denotes T-score height threshold and the upper limit denotes maximum peak value (À21 mm, À54 mm, 14 mm). , but did not survive correction for multiple comparisons (p FWER-corr <0.008). The lower limit of the color bar denotes T-score height threshold and the upper limit denotes maximum peak value (À36 mm, 18 mm, 28 mm). Symbols mark the cortical area of association (*: middle frontal gyrus and sulcus; **: inferior frontal sulcus and inferior part of precentral sulcus; ▴: central sulcus; ▴▴: intraparietal sulcus and transverse parietal sulci; ▴▴▴: superior frontal gyrus, and anterior cingular gyrus and sulcus; þ: superior frontal sulcus; þþ: circular sulcus of the insula; þþþ: anterior cingular gyrus and sulcus).
sex hormones (Gorzalka and Dang, 2012) , inconsistencies between results may be due to differences in hormonal status of female subjects. For example, circulating estradiol levels can vary ten-fold during the normal ovarian cycle (Stricker et al., 2006) . Estrogen significantly affects CB1R agonist binding (Riebe et al., 2010) and increase AEA synthesis in the hypothalamus (Scorticati et al., 2004) , while AEA regulates central gonadotropin secretion influencing sex steroid levels (Scorticati et al., 2004) . Previous literature on sex difference of endocannabinoid levels in cerebrospinal fluid or peripheral blood is inconclusive with mixed results. Most studies report no major differences of EC levels between males and females (Blüher et al., 2006; Zelber-Sagi et al., 2017; Walter et al., 2013; Schroeder et al., 2009; Koltyn et al., 2014; Fanelli et al., 2012 Fanelli et al., , 2017 Mallipedhi et al., 2015; Nicholson et al., 2015; Giuffrida et al., 2004) but the link between peripheral ECS drive and central CB1 receptor availability is not known (Hillard, 2017) . In our sample, females using combined oral contraceptives, a combination of estrogen and progesterone, tended to have lower mean CB1R availability compared to that of females without hormonal contraception. The inter-subject variation of [ 18 F]FMPEP-d2 V T within the studied areas did not differ between males and females suggesting that the putative effect of combined oral contraceptives, or estrous cycle status, is subordinate to the overall sex effect (McCarthy et al., 2012) . However, the effect of contraceptives on CB1R availability cannot be generalized due to cross-sectional study design and a small sample size. It is possible that this association is caused by other circumstances co-occurring with oral contraceptive use. Notably one previous study reported that CB1R binding did not differ between premenopausal females on and off contraceptives (Van Laere et al., 2008) . The lack of detailed estrous cycle data and used contraceptive characteristics makes it very difficult to assess comparability of studies in this regard (Neumeister et al., 2013; Normandin et al., 2015; Van Laere et al., 2008) . It is notable that the previous study reporting a lower CB1R availability in males used [ specific binding to CB1R that can be displaced with rimonabant. However, this does not necessarily mean that the tracers label exactly same receptor populations. A substantial portion of CB1R are known to undergo receptor internalization processes (Hsieh et al., 2002) , the CB1R exists in multiple affinity states in relation to agonist activity (Gullapalli et al., 2010) , and appears to have many regulatory protein interactions (Smith et al., 2015) . More specifically, CB1R exist in an active conformation associated with coupling to and activating G-proteins, as well as an inactive conformation (Hua et al., 2017; Shao et al., 2016) . Antagonists/inverse antagonists have equal affinities to the active and inactive states of CB1R, and agonists have preference for the active state. While a substantial majority of CB1R on the neuronal membrane reside in the inactive state, agonists are thought to shift this proportion of active/-inactive conformities towards the active state (Gullapalli et al., 2010) . It is thus possible that using radiotracers differing in affinity, lipophilicity, receptor-ligand interactions, and scan times may lead to differences in distribution volumes. (Terry et al., 2010a) , and any non-significant differences in the transport of tracer from blood to tissue compartments are very unlikely to explain any robust differences in V T .
Opposite results of CB1R V T using FMPEP-d2 V T remained lower compared to controls after 2-4 weeks of abstinence , while [ 11 C]OMAR V T was higher after 4 weeks of alcohol abstinence (Neumeister et al., 2012) . Additionally, in a study of CB1R in cannabis dependence, cannabis dependent males had 20% lower [ 18 F]FMPEP-d2 V T , which increased to control levels after 4 weeks of abstinence . Chronic cannabis use similarly resulted in~15% lower V T with [ 11 C]OMAR. However, this level increased significantly after only two days of abstinence (D'Souza et al., 2016) . The initial depression is consistent with CB1R down-regulation secondary to chronic CB1R agonist Δ9-THC exposure (Breivogel et al., 1999; Laprairie et al., 2014; Corchero et al., 1999) , but the prompt increase of V T could also be explained by depletion of cumulated Δ9-THC from adipocytes (Gunasekaran et al., 2009) . Curiously, higher binding of [ 3 H]OMAR to prefrontal cortex cryosections was found to be inversely associated to CB1R protein and mRNA levels in an ex vivo sample of schizophrenia patients (Volk et al., 2014) . This was suggested to reflect alterations in receptor affinity, or trafficking within the neuron. Differences in tracer selectivity balances of CB1R/CB2R binding, inverse association of [
11 C]OMAR to CB1R agonist activity, or related affinity changes, could also explain the results discussed above. However, these suggestions are highly speculative and cannot be resolved without a cross validation study with [ Definitive conclusions about the functional consequences of the observed sex difference cannot be made at this time due to the elusive and highly intricate regulation of CB1R protein expression, trafficking and degradation. One possible explanation is that higher CB1R availability in males could reflect regulation of receptor protein density in the context of lower ECS signaling. This interpretation is supported by previous observations of reduced CB1R V T secondary to chronic cannabis use , and reduced CB1R mRNA (Corchero et al., 1999) and agonist binding (Breivogel et al., 1999) after chronic Δ9-THC in adult male rats. Genetic and pharmacological knockout of monoacylglycerol lipase (MAGL), the main degradative enzyme of 2-AG, induces CB1R downregulation and desensitization in the mouse brain (Schlosburg et al., 2010) , which suggests that the sex difference in CB1R availability may be mediated by 2-AG signaling. However, the regulation of CB1R mRNA and protein is complex, as shown in a cell culture study of acute and chronic endocannabinoid effects (Laprairie et al., 2014) . Here AEA and 2-AG seemed to display functional selectivity for second messenger activation, which has relevance for rates of receptor internalization, subsequent degradation, and replenishment of presynaptic membrane CB1R populations. Since endocannabinoid synthesis pathways are dissociated and differentially regulated (Lu and MacKie, 2016; Hill and Tasker, 2012; Maccarrone et al., 2008) , it is also possible that the current findings may be explained by alterations in endogenous cannabinoid agonists such as specific balances of AEA and 2-AG levels. Allosteric CB1R modulators pregnenolone and lipoxin A4 might also contribute to the observed effect (Morales et al., 2016) . The CB1R sex difference was regionally specific with statistically significant differences in both cortical and subcortical regions. The largest effect of different CB1R availability in males and females was centered in and around the posterior cingulate area, which contains the retrospenial cortex (RSC) and parahippocampal cortex (PHC). These areas are suggested to encode the spatial layout and location of specific visual scenes within a larger spatial environment (Epstein, 2008) .
Recently, sex differences in functional association of these areas to scene-selective stimuli were replicated in a large sample of healthy controls (Zhen et al., 2017) . The RSC has been also suggested to be responsible for transformation of information from a self-centered viewpoint to a world-centered spatial framework (Vann et al., 2009) , and has also been found to be involved in speech production and comprehension (Awad et al., 2007) . Although the nature of RSC processing of speech is not known, it is intriguing to speculate the implications of putative dysfunctional spatial encoding of internal speech in the context of auditory hallucinations. Functional connectivity of the RSC to the superior temporal gyrus, an area involved in auditory processing and language comprehension, seems to be increased in schizophrenia (Bluhm et al., 2009) . It is thus possible that a lower ECS drive in males could result in a predisposition to aberrant spatial encoding of speech, manifesting as a vulnerability to auditory hallucinations.
We also found negative associations of visuospatial working memory performance to CB1R availability. The associated areas correspond to cortical regions previously suggested to participate in visuospatial working memory, and processing of the attentional priority of memory content (Jerde and Curtis, 2013; Constantinidis and Klingberg, 2016) . We suggest that ECS tonus modulates the balance of excitation and inhibition of cortical primary neurons in a bilateral occipito-parieto-frontal network responsible for sustaining behaviorally relevant visuospatial content in working memory. For example, lower ECS tone could reduce synchronisation of excitatory afferents and cortical activity, via reduced suppression of inhibition in cortical interneurons, resulting in gradual drifting of working memory content from the origin (Wimmer et al., 2014) . The observed association parallels the effects of exogenic CB1R agonists on spatial working memory performance (Jentsch, 1997; Verrico et al., 2014) . It is possible that, by disrupting the temporal-spatial selectivity of endocannabinoid neurotransmission, exogenous agonists similarly impair synchronised neural oscillations. On the other hand, an overactive ECS could also result in ineffective working memory through excessive high-pass filtering of pertubing excitatory activity.
It is notable that males and females did not differ in years of received education, level of functioning, or neuropsychological test scores. Thus, the observed association to visuospatial performance could be secondary to a compensated developmental factor. This indicates that the ECS is calibrated during neurodevelopment to provide an optimal behavioral level in the context of other neurotransmitter system states (Blume et al., 2013) , hormonal influences (Peterson et al., 2016) and/or environmental influences (Su arez et al., 2009 ). However, this interpretation is restricted by insufficient statistical power. Subtle sex differences in visuospatial test performance in our sample cannot be entirely ruled out. The ECS may also be involved in other neuropsychological functions with putative sex differences, such as verbal fluency (Scheuringer and Pletzer, 2017) .
The ECS affects biologically fundamental brain functions by gating the hypothalamus-pituitary-adrenocortical axis (HPAA) stress response (Roberts et al., 2014) , and striatal dopamine release by local circuit modulation of amygdala and midbrain efferents respectively (Covey et al., 2017) . Differences of ECS drive in males and females might thus manifest as different sensitivies to HPAA activity, or striatal dopamine release in response to stress (Dlugos et al., 2012) , a transdiagnostic psychiatric risk factor (Agid et al., 2000) . This theoretical link between sex dependent psychiatric vulnerabilities and the ECS is supported by observations of the intermediary role of the ECS in estradiol effects on addiction (Peterson et al., 2016) and anxiety behaviour (Hill et al., 2007) in female rats. Estradiol also seems to affect hippocampal inhibitory interneuron activity differently in males and females through an ECS dependent mechanism (Tabatadze et al., 2015) . Whatever the origin, alternate tones of CB1R mediated modulation could nevertheless be manifested as differences in cognitive performance and responses to stress. Studying ECS function separately in male and female psychosis patients or other relevant syndromes are needed to elucidate whether the observed sex differences are relevant in the context of psychiatric vulnerability.
Conclusions
We observed robust gender differences in CB1R availability with large effect sizes. The widespread effect was regionally selective with the most pronounced effects observed in the posterior limbic cortex. Our results also suggest an association between CB1R availability and visuospatial functioning, a domain suggested to have sex differences in the general population. In addition, combined hormonal contraceptives seemed to affect CB1 receptor availability but this should be further investigated with a larger sample size and detailed characterization of hormonal status. Finally, these results implicate that future human studies of ECS function in different neuropsychiatric disorders should closely control the effects of sex and hormonal status.
